Eli Lilly looking for new drug support

Indianapolis: Eli Lilly, maker of the blockbuster drug Prozac, has

solicited RFIs from several healthcare agencies for future product

launches currently in the pipeline.

Although the pharmaceutical giant would not discuss the products

involved, Eli Lilly is expected to launch three drugs in 2002:

Atomoxetine (a treatment for attention deficit hyperactivity disorder),

Duloxetine (for depression), and Cialis (a potential blockbuster drug

that will go face-to-face with Viagra as a treatment for erectile

dysfunction in men).

"For us, this is a routine part of business," said Jeff Newton, director

of marketing communications for Eli Lilly. "We're at the point now where

we're ready to move on to the next phase."

The company said that it was not actively seeking pitches from agencies

that it hadn't already approached.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Recommended for you

Recommended for you

Explore further